Amine-containing drugs often show poor pharmacological properties, but these disadvantages can be overcome by using a prodrug approach involving self-immolative linkers. Accordingly, we designed l-lactate linkers as ideal candidates for amine delivery. Furthermore, we designed linkers bearing two different cargos (aniline and phenol) for preferential amine cargo release within 15 min. Since the linkers carrying secondary amine cargo showed high stability at physiological pH, we used our strategy to prepare phosphate-based prodrugs of the antibiotic Ciprofloxacin. Therefore, our study will facilitate the rational design of new and more effective drug delivery systems for amine-containing drugs.

Faculty of Science Charles University 128 43 Prague Czech Republic

Institute of Organic Chemistry and Biochemistry The Czech Academy of Sciences 166 10 Prague Czech Republic

Zobrazit více v PubMed

Barbosa-Filho J.M., Piuvezam M.R., Moura M.D., Silva M.S., Lima K.V.B., da-Cunha E.V.L., Fechine I.M., Takemura O.S. Anti-inflammatory activity of alkaloids: A twenty-century review. Rev. Bras. Farmacogn. 2006;16:109–139. doi: 10.1590/S0102-695X2006000100020. DOI

Ballout F., Habli Z., Monzer A., Rahal O.N., Fatfat M., Gali-Muhtasib H. Bioactive Natural Products for the Management of Cancer: From Bench to Bedside. Springer; Singapore: 2019. Anticancer Alkaloids: Molecular Mechanisms and Clinical Manifestations; pp. 1–35.

Mohan K., Jeyachandran R. Alkaloids as anticancer agents. Ann. Phytomed. 2012;1:46–53.

Krishnan N., Devadasan V., Raman P. Plant-derived alkaloids as anti-viral agents. Int. J. Res. Pharm. Sci. 2020;11:6174–6182. doi: 10.26452/ijrps.v11i4.3291. DOI

Cushnie T.P.T., Cushnie B., Lamb A.J. Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Int. J. Antimicrob. Agents. 2014;44:377–386. doi: 10.1016/j.ijantimicag.2014.06.001. PubMed DOI

Sayhan H., Beyaz S.G., Çeliktaş A. Alkaloids—Alternatives in Synthesis, Modification and Application. InTechOpen; London, UK: 2017. The Local Anesthetic and Pain Relief Activity of Alkaloids. DOI

Krise J.P., Oliyai R. Prodrugs of Amines. In: Stella V., Borchardt R., Hageman M., Oliyai R., Maag H., Tilley J.E., editors. Prodrugs. Springer; New York, NY, USA: 2008. pp. 801–831.

Albert A. Chemical aspects of selective toxicity. Nature. 1958;182:421–423. doi: 10.1038/182421a0. PubMed DOI

Abet V., Filace F., Recio J., Alvarez-Builla J., Burgos C. Prodrug approach: An overview of recent cases. Eur. J. Med. Chem. 2017;127:810–827. doi: 10.1016/j.ejmech.2016.10.061. PubMed DOI

Rautio J., Kumpulainen H., Heimbach T., Oliyai R., Oh D., Järvinen T., Savolainen J. Prodrugs: Design and clinical applications. Nat. Rev. Drug Discov. 2008;7:255–270. doi: 10.1038/nrd2468. PubMed DOI

Simplício A.L., Clancy J.M., Gilmer J.F. Prodrugs for amines. Molecules. 2008;13:519–547. doi: 10.3390/molecules13030519. PubMed DOI PMC

Alouane A., Labruère R., Le Saux T., Schmidt F., Jullien L. Self-immolative spacers: Kinetic aspects, structure-property relationships, and applications. Angew. Chem.-Int. Ed. 2015;54:7492–7509. doi: 10.1002/anie.201500088. PubMed DOI

Gonzaga R.V., do Nascimento L.A., Santos S.S., Machado Sanches B.A., Giarolla J., Ferreira E.I. Perspectives About Self-Immolative Drug Delivery Systems. J. Pharm. Sci. 2020;109:3262–3281. doi: 10.1016/j.xphs.2020.08.014. PubMed DOI

Teicher B.A., Chari R.V.J. Antibody conjugate therapeutics: Challenges and potential. Clin. Cancer Res. 2011;17:6389–6397. doi: 10.1158/1078-0432.CCR-11-1417. PubMed DOI

Egron D., Lefebvre I., Périgaud C., Beltran T., Pompon A., Gosselin G., Aubertin A.M., Imbach J.L. Anti-HIV pronucleotides: Decomposition pathways and correlation with biological activities. Bioorg. Med. Chem. Lett. 1998;8:1045–1050. doi: 10.1016/S0960-894X(98)00158-9. PubMed DOI

Wei Y., Qiu G., Lei B., Qin L., Chu H., Lu Y., Zhu G., Gao Q., Huang Q., Qian G., et al. Oral Delivery of Propofol with Methoxymethylphosphonic Acid as the Delivery Vehicle. J. Med. Chem. 2017;60:8580–8590. doi: 10.1021/acs.jmedchem.7b01133. PubMed DOI

Mehellou Y., Rattan H.S., Balzarini J. The ProTide Prodrug Technology: From the Concept to the Clinic. J. Med. Chem. 2018;61:2211–2226. doi: 10.1021/acs.jmedchem.7b00734. PubMed DOI PMC

Ray A.S., Fordyce M.W., Hitchcock M.J.M. Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus. Antivir. Res. 2016;125:63–70. doi: 10.1016/j.antiviral.2015.11.009. PubMed DOI

McQuaid T., Savini C., Seyedkazemi S. Sofosbuvir, a significant paradigm change in hcv treatment. J. Clin. Transl. Hepatol. 2015;3:27–35. PubMed PMC

Siegel D., Hui H.C., Doerffler E., Clarke M.O., Chun K., Zhang L., Neville S., Carra E., Lew W., Ross B., et al. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses. J. Med. Chem. 2017;60:1648–1661. doi: 10.1021/acs.jmedchem.6b01594. PubMed DOI

Klán P., Šolomek T., Bochet C.G., Blanc A., Givens R., Rubina M., Popik V., Kostikov A., Wirz J. Photoremovable protecting groups in chemistry and biology: Reaction mechanisms and efficacy. Chem. Rev. 2013;113:119–191. doi: 10.1021/cr300177k. PubMed DOI PMC

Procházková E., Šimon P., Straka M., Filo J., Majek M., Cigáň M., Baszczyňski O. Phosphate Linkers with Traceable Cyclic Intermediates for Self-Immolation Detection and Monitoring. Chem. Commun. 2020;57:211–214. doi: 10.1039/D0CC06928K. PubMed DOI

Zhang S., Wang H., Shen Y., Zhang F., Seetho K., Zou J., Taylor J.S.A., Dove A.P., Wooley K.L. A simple and efficient synthesis of an acid-labile polyphosphoramidate by organobase-catalyzed ring-opening polymerization and transformation to polyphosphoester ionomers by acid treatment. Macromolecules. 2013;46:5141–5149. doi: 10.1021/ma400675m. PubMed DOI PMC

Procházková E., Filo J., Cigáň M., Baszczyňski O. Sterically-Controlled Self-Immolation in Phosphoramidate Linkers Triggered by Light. Eur. J. Org. Chem. 2020;2020:897–906. doi: 10.1002/ejoc.201901882. DOI

Šimon P., Tichotová M., Gallardo M.G., Procházková E., Baszczynski O. Phosphate-Based Self-Immolative Linkers for Tunable Double Cargo Release. Chem. A Eur. J. doi: 10.1002/chem.202101805. in press. PubMed DOI

Mulliez M., Wolf R. Contraste entre la phosphorylation des alcools et des amines par les 2-4 dioxo, oxa-1, aza-3 phospholanes-2. Bull. Soc. Chim. Fr. 1986:101–108.

Jafar N.N.A., Majeed N.S. Microwave-assisted synthesis and biological activity of ester, carbothioate and carbohydrazide derivative compounds of the drug Ciprofloxacin. J. Chem. Pharm. Sci. 2017;10:515–521.

Albert A., Goldacre R., Phillips J. 455. The strength of heterocyclic bases. J. Chem. Soc. 1948:2240–2249. doi: 10.1039/jr9480002240. DOI

Dudkin S.M., Ledneva R.K., Shabarova Z.A., Prokofiev M.A. Hydrolysis of uridine-5′ N-aryl and N-alkyl phosphoramidates by ribonucleoside-5′ phosphoramidase. FEBS Lett. 1971;16:48–50. doi: 10.1016/0014-5793(71)80682-8. PubMed DOI

Beltran T., Egron D., Pompon A., Lefebvre I., Périgaud C., Gosselin G., Aubertin A.M., Imbach J.L. Rational design of a new series of pronucleotide. Bioorg. Med. Chem. Lett. 2001;11:1775–1777. doi: 10.1016/S0960-894X(01)00299-2. PubMed DOI

Drontle D. Designing a Pronucleotide Stratagem: Lessons from Amino Acid Phosphoramidates of Anticancer and Antiviral Pyrimidines. Mini Rev. Med. Chem. 2004;4:409–419. doi: 10.2174/1389557043403945. PubMed DOI

Kanzian T., Nigst T.A., Maier A., Pichl S., Mayr H. Nucleophilic Reactivities of Primary and Secondary Amines in Acetonitrile. Eur. J. Org. Chem. 2009:6379–6638. doi: 10.1002/ejoc.200900925. DOI

Sachin K., Kim E.M., Cheong S.J., Jeong H.J., Lim S.T., Sohn M.H., Kim D.W. Synthesis of N 4′-[18F]fluoroalkylated ciprofloxacin as a potential bacterial infection imaging agent for PET study. Bioconjug. Chem. 2010;21:2282–2288. doi: 10.1021/bc1002983. PubMed DOI